TY - JOUR T1 - Sex-based differences in clearance of chronic <em>Plasmodium falciparum</em> infection JF - medRxiv DO - 10.1101/2020.06.10.20127720 SP - 2020.06.10.20127720 AU - Jessica Briggs AU - Noam Teyssier AU - Joaniter I. Nankabirwa AU - John Rek AU - Prasanna Jagannathan AU - Emmanuel Arinatiwe AU - Teun Bousema AU - Chris Drakeley AU - Margaret Murray AU - Emily Crawford AU - Nicholas Hathaway AU - Sarah G. Staedke AU - David Smith AU - Phillip J. Rosenthal AU - Moses Kamya AU - Grant Dorsey AU - Isabel Rodriguez-Barraquer AU - Bryan Greenhouse Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/28/2020.06.10.20127720.abstract N2 - Multiple studies have reported a male bias in incidence and/or prevalence of malaria infection in males compared to females. To test the hypothesis that sex-based differences in host-parasite interactions affect the epidemiology of malaria, we intensively followed Plasmodium falciparum infections in a cohort in a malaria endemic area of eastern Uganda and estimated both force of infection (FOI) and rate of clearance using amplicon deep-sequencing. We found no evidence of differences in behavioral risk factors, incidence of malaria, or FOI by sex. In contrast, females cleared asymptomatic infections at a faster rate than males (hazard ratio [HR] = 1.82, 95% CI 1.20 to 2.75 by clone and HR = 2.07, 95% CI 1.24 to 3.47 by infection event) in multivariate models adjusted for age, timing of infection onset, and parasite density. These findings implicate biological sex-based differences as an important factor in the host response to this globally important pathogen.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding was provided by the National Institutes of Health as part of the International Centers of Excellence in Malaria Research (ICMER) program (U19AI089674). JB is supported by the National Institutes of Health training grant T32 AI007641-16. JIN is supported by the Fogarty International Center (Emerging Global Leader Award grant number K43TW010365). EA is supported by the Fogarty International Center of the National Institutes of Health under Award Number D43TW010526. The ClinEpiDB platform is supported by award OPP1169785 from the Bill &amp; Melinda Gates Foundation. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study protocol was approved by both the UCSF IRB and the UNCST IRB in Uganda.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available by request from the authors. After acceptance and publication by a peer-reviewed journal, all data will be published on ClinEpiDB.org. ER -